These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 949860)

  • 41. Relation of monocyte and neutrophil oxidative metabolism to skin and oral lesions in carriers of chronic granulomatous disease.
    Kragballe K; Borregaard N; Brandrup F; Koch C; Staehrjohansen K
    Clin Exp Immunol; 1981 Feb; 43(2):390-8. PubMed ID: 7273485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A variant form of X-linked chronic granulomatous disease with normal nitroblue tetrazolium slide test and cytochrome b.
    Borregaard N; Cross AR; Herlin T; Jones OT; Segal AW; Valerius NH
    Eur J Clin Invest; 1983 Jun; 13(3):243-8. PubMed ID: 6409648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NBT reduction by exudate neutrophils in carriers of chronic granulomatous disease.
    Kowolik MJ; Raeburn JA
    J Infect; 1983 Jan; 6(1):96-7. PubMed ID: 6886451
    [No Abstract]   [Full Text] [Related]  

  • 45. Letter: Defective microbicidal function.
    van der Meer JW; van Furth R; Weemaes CM; van Zwet TL
    Lancet; 1976 Feb; 1(7954):305-6. PubMed ID: 55617
    [No Abstract]   [Full Text] [Related]  

  • 46. Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers.
    Tsilifis C; Torppa T; Williams EJ; Albert MH; Hauck F; Soncini E; Kang E; Malech H; Schuetz C; von Bernuth H; Slatter MA; Gennery AR
    J Clin Immunol; 2023 Nov; 43(8):1964-1973. PubMed ID: 37620741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic Granulomatous Disease.
    Rawat A; Bhattad S; Singh S
    Indian J Pediatr; 2016 Apr; 83(4):345-53. PubMed ID: 26865172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Staining of eosinophils with nitroblue tetrazolium in patients with chronic granulomatous disease.
    Roberts RL; Ohno Y; Gallin JI
    Pediatr Res; 1986 Apr; 20(4):378-80. PubMed ID: 2422626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic granulomatous disease in two sisters.
    D'Amelio R; Bellavite P; Bianco P; de Sole P; Le Moli S; Lippa S; Seminara R; Vercelli B; Rossi F; Rocchi G
    J Clin Immunol; 1984 May; 4(3):220-7. PubMed ID: 6330157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. X-linked chronic granulomatous disease secondary to skewed X-chromosome inactivation in female patients.
    Zhang Y; Shu Z; Li Y; Piao Y; Sun F; Han T; Wang T; Mao H
    Clin Exp Immunol; 2024 Feb; 215(3):261-267. PubMed ID: 38066563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nitroblue-tetrazolium tests.
    Segal AW
    Lancet; 1974 Nov; 2(7891):1248-52. PubMed ID: 4139481
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions.
    Emmendörffer A; Nakamura M; Rothe G; Spiekermann K; Lohmann-Matthes ML; Roesler J
    Cytometry; 1994 Sep; 18(3):147-55. PubMed ID: 7813334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NADPH oxidase deficiency in X-linked chronic granulomatous disease.
    Hohn DC; Lehrer RI
    J Clin Invest; 1975 Apr; 55(4):707-13. PubMed ID: 235560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ["Pseudo-lupus" eruptions in a mother carrying X chromosome-linked chronic septic granulomatosis].
    Cuny JF; Chauvel F; Schmutz JL; Bordigoni P; Weber M; Beurey J
    Ann Dermatol Venereol; 1990; 117(10):713-8. PubMed ID: 2073062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology.
    Cale CM; Morton L; Goldblatt D
    Clin Exp Immunol; 2007 Apr; 148(1):79-84. PubMed ID: 17286762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Chronic granulomatous disease (CGD): in vitro enhancement of bactericidal activity of CGD phagocytes by rifampicin].
    Samson J; Lapointe N
    Ann Immunol (Paris); 1977; 128(1-2):75-6. PubMed ID: 848909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA; Orkin SH; Newburger PE
    J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deficiency of NADPH oxidase activity in chronic granulomatous disease.
    McPhail LC; DeChatelet LR; Shirley PS; Wilfert C; Johnston RB; McCall CE
    J Pediatr; 1977 Feb; 90(2):213-7. PubMed ID: 12254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.
    Köker MY; Sanal O; de Boer M; Tezcan I; Metin A; Tan C; Ersoy F; Roos D
    Eur J Clin Invest; 2006 Apr; 36(4):257-64. PubMed ID: 16620288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lupus like lesions in a patient with X-linked chronic granulomatous disease and recombinant X chromosome.
    Ortiz-Romero PL; Corell-Almuzara A; Lopez-Estebaranz JL; Arranz FR; Ruiz-Contreras J
    Dermatology; 1997; 195(3):280-3. PubMed ID: 9407182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.